Consolidated Statements of Cash Flows (USD $) In Thousands	12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 27, 2009
Cash flows from operating activities:
Net income	$ 489,009	$ 125,139	$ 10,455
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	94,297	93,525	196,108
Depreciation and amortization	205,062	167,523	205,423
Deferred taxes	140,084	29,090	202,352
In process research & development	0	0	3,900
Loss from sale of property, plant and equipment	12,946	272	2,695
Loss (gain) from sale of equity investments	0	148	(529)
Tax benefit (shortfall) related to stock-based compensation	30,546	(15,748)	(216,835)
Excess tax benefit related to stock-based compensation	(12,869)	(7,005)	(670)
Impairment of long-lived assets	0	8,291	51,112
Changes in assets and liabilities:
Accounts receivable	43,256	(124,258)	65,288
Inventories	(29,435)	22,681	49,124
Other current assets	53,255	(79,319)	3,226
Accounts payable	(4,746)	41,191	(5,988)
Income taxes payable	(45,318)	17,384	15,545
Deferred income on shipments to distributors	11,102	9,020	(4,687)
Accrued liabilities- tender offer payments above settlement date fair value	0	0	(8,665)
Accrued liabilities - goodwill payments above settlement date fair value	(164)	(1,328)	(32,016)
Accrued liabilities - litigation settlement	(173,000)	173,000	0
All other accrued liabilities	47,429	31,347	(90,043)
Net cash provided by operating activities	861,454	490,953	445,795
Cash flows from investing activities:
Purchases of property, plant and equipment	(175,253)	(123,901)	(135,429)
Proceeds from sale of property, plant, and equipment	27,624	2,802	947
Acquisitions	(80,918)	(316,784)	(61,010)
Other non-current assets	0	(3,998)	873
Purchases of available-for-sale securities	(49,787)	0	(5,524)
Proceeds from sales/maturities of available-for-sale securities	0	200,233	8,426
Net cash used in investing activities	(278,334)	(241,648)	(191,717)
Cash flows from financing activities
Excess tax benefit from stock-based compensation plans	12,869	7,005	670
Mortgage liability	(3,237)	(40)	(40)
Equity settlements and payouts under the RSU loan program	26	(784)	(50,432)
Proceeds from derivative litigation settlement	0	2,460	0
Repayment of notes payable	(1,422)	0	(3,827)
Long-term debt, net of issuance costs	0	298,578	0
Issuance of common stock	24,830	(4,700)	(20,587)
Repurchase of common stock	(231,012)	(190,905)	(235,132)
Dividends paid	(249,145)	(243,755)	(248,501)
Net cash used in financing activities	(447,091)	(132,141)	(557,849)
Net increase (decrease) in cash and cash equivalents	136,029	117,164	(303,771)
Cash and cash equivalents:
Beginning of year	826,512	709,348	1,013,119
End of year	962,541	826,512	709,348
Supplemental disclosures of cash flow information:
Cash (refunded) paid, net during the year for income taxes	(15,529)	217,140	21,650
Cash paid for interest	10,264	0	0
Noncash financing and investing activities:
Accounts payable related to property, plant and equipment purchases	$ 22,841	$ 6,894	$ 15,712